好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Global Health Challenges: Neurology in Developing Countries

Monday 04/23/12
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Jerome H. Chin, MD, PhD, MPH, FAAN
Global Health and Neuroepidemiology
Participants should be able to identify the major global risk factors for non-communicable diseases including stroke; list the most frequent nervous system infections in developing countries; discuss the role of international agencies and NGOs in the care and treatment of people with neurological disorders; and review the key barriers to conducting basic and clinical research in resource-limited countries.
No CME available
Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Didactic

Program Evaluations

Event Timeline
06:30 AM - 07:00 AM The Chronic Disease Pandemic: Time for Action
Jerome H. Chin, MD, PhD, MPH, FAAN
06:30 AM - 08:30 AM Break
07:00 AM - 07:30 AM Neurological Infections in the Developing World
Allen J. Aksamit, Jr., MD, FAAN
07:30 AM - 08:00 AM Neurology and Global Organizations
Farrah J. Mateen, MD, PhD, FAAN
08:00 AM - 08:30 AM Real Life Global Health Challenges
James H. Bower, MD, MSc, FAAN
Faculty Disclosures
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Jerome H. Chin, MD, PhD, MPH, FAAN Dr. Chin has received publishing royalties from a publication relating to health care.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.